Patent AnalyticsExaminers
Rankings

Company or institution

ATROGI AB

26 applicationsfiled 2015 to 2025

Allowance rate
68%
−7 pts vs the USPTO range 46% to 85%
Rejections before allowance
1.1
−0.5 vs the USPTO
Months to first action
21.0 mo
+2.4 vs the USPTO
Needed an RCE
20%
−7 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

A61K Medical preparations12 apps
C07D Heterocyclic compounds5 apps
G01N Investigating or analysing materials4 apps
A61P Therapeutic activity of compounds3 apps
C07C 1 apps
C12Q Measuring or testing processes involving enzymes or nucleic acids1 apps

Art units

16214 apps
16283 apps
16263 apps
OPAP3 apps
16252 apps
16512 apps

Who represents them

Law firms and agents on their applications

Bars show the share of decided applications that were allowed.

Unlock the firms on their applicationsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

ApplicationTitleFiledStatusRejectionsRCEsTo 1st action
19620270COMBINATIONS OF BETA 2-ADRENERGIC RECEPTOR AGONISTS AND SGLT2 INHIBITORS FOR USE IN…2026-09-01Pending00n/a
19469413HETEROCYCLOALKYL BETA-HYDROXY ALKYL AMINES FOR USE IN THE TREATMENT OF HYPERGLYCAEM…2025-09-26Pending00n/a
19469415CYCLOHEXYL OR HETEROCYCLOALKYL BETA-HYDROXY ALKYL AMINES FOR USE IN THE TREATMENT O…2025-09-26Pending00n/a
15565173Method and apparatus for adaptive signal processing2012-01-10Allowed1012.0 mo
15582812Composition and method for controlled release2015-02-11Abandoned4123.0 mo
15704289Distributed ledger transaction verification2018-03-12Allowed3020.0 mo
15413538Thermal management of battery assemblies2021-04-13Pending2117.0 mo
15559490Machine learning model for anomaly detection2012-05-14Allowed1014.0 mo
15972011Wireless power transfer coil arrangement2015-06-15Abandoned4125.0 mo
15817131Catalyst for selective hydrogenation2018-07-16Allowed3022.0 mo
Unlock all 26 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in